GRK 2 Antibody

<strong>GRK 2 Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2015996_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 80 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8° C_x000D_ <strong>Keywords:</strong> GRK 2 Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Arinobu D, Tachibanaki S, Kawamura S. Larger inhibition of visual pigment kinase in cones than in rods J Neurochem. 2010 Oct;115(1):259-68._x000D_ 2: Singh C, Verma S, Reddy P, Diamond MS, Curiel DT, Patel C, Jain MK, Redkar SV, Bhate AS, Gundappa V, Konatham R, Toppo L, Joshi AC, Kushwaha JS, Singh AP, Bawankule S, Ella R, Prasad S, Ganneru B, Chiteti SR, Kataram S, Vadrevu KM. Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin(®)) NPJ Vaccines. 2023 Aug 18;8(1):125._x000D_ 3: Crudden C, Shibano T, Song D, Dragomir MP, Cismas S, Serly J, Nedelcu D, Fuentes-Mattei E, Tica A, Calin GA, Girnita A, Girnita L. Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth Cancer Res. 2021 Jan 15;81(2):501-514._x000D_ 4: Hill BT, Ma S, Zent CS, Baran AM, Wallace DS, Advani A, Winter A, Winter J, Gordan L, Karmali R, Liesveld JL, Mulford DA, Rowland C, Bui A, Sportelli P, Miskin HP, Weiss MS, Friedberg JW, Barr PM. Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia Blood Adv. 2024 Jan 23;8(2):378-387._x000D_ 5: Hauser A, Poulou E, Müller F, Schmieder P, Hackenberger CPR. Synthesis and Evaluation of Non-Hydrolyzable Phospho-Lysine Peptide Mimics Chemistry. 2021 Feb 1;27(7):2326-2331._x000D_ 6: Miralles A, Asensio VJ, García-Sevilla JA. Acute treatment with the cyclic antidepressant desipramine, but not fluoxetine, increases membrane-associated G protein-coupled receptor kinases 2/3 in rat brain Neuropharmacology. 2002 Dec;43(8):1249-57._x000D_ 7: Tran TM, Jorgensen R, Clark RB. Phosphorylation of the beta2-adrenergic receptor in plasma membranes by intrinsic GRK5 Biochemistry. 2007 Dec 18;46(50):14438-49._x000D_ 8: Tran TM, Friedman J, Baameur F, Knoll BJ, Moore RH, Clark RB. Characterization of beta2-adrenergic receptor dephosphorylation: Comparison with the rate of resensitization Mol Pharmacol. 2007 Jan;71(1):47-60._x000D_ 9: Leitner MG, Thallmair V, Wilke BU, Neubert V, Kronimus Y, Halaszovich CR, Oliver D. The N-terminal homology (ENTH) domain of Epsin 1 is a sensitive reporter of physiological PI(4,5)P(2) dynamics Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Mar;1864(3):433-442._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/11171671">10: Schutzer WE, Reed JF, Bliziotes M, Mader SL. Upregulation of G protein-linked receptor kinases with advancing age in rat aorta Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R897-903. </a>_x000D_ _x000D_ <strong>Products Related to GRK 2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>